Press Releases

$Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting$

December 7, 2025

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

GlobeNewswire, Inc.

$Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting$

December 7, 2025

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

GlobeNewswire, Inc.

December 6, 2025

Recent French Survey Highlights Religion Discrimination

MENAFN

Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate

Owned By	Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded	2000
Website	menafn.com
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

December 7, 2025

Deaf Guides Explore Nepal’s Culture, Mountains

MENAFN

Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate

Owned By	Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded	2000
Website	menafn.com
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

December 6, 2025

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

GlobeNewswire, Inc.

December 6, 2025

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

GlobeNewswire, Inc.

December 7, 2025

Cold Weather Alert - Overnight December 7, 2025

City of Hamilton

Owner: Canadian Government

City of Hamilton

Indeterminate

Owned By	Canadian Government
Year Founded	1792
Website	www.hamilton.ca
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Canada, Ontario
Owner Country	Canada

We welcome your feedback!
If you have comments or corrections, let us know.

December 7, 2025

City transitions water billing services with a streamlined approach

City of Hamilton

Owner: Canadian Government

City of Hamilton

Indeterminate

Owned By	Canadian Government
Year Founded	1792
Website	www.hamilton.ca
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Canada, Ontario
Owner Country	Canada

We welcome your feedback!
If you have comments or corrections, let us know.

December 6, 2025

Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire, Inc.

$Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH)…$

December 6, 2025

Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH)…

GlobeNewswire, Inc.

December 6, 2025

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human…

GlobeNewswire, Inc.

December 6, 2025

Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)

GlobeNewswire, Inc.

December 6, 2025

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

GlobeNewswire, Inc.

December 6, 2025

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

GlobeNewswire, Inc.

December 6, 2025

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

GlobeNewswire, Inc.

December 5, 2025

“Art From the Eye of India” Hosted by Luxury Interior Designer Nina Magon, Bestselling Poet Rupi Kaur, and Acclaimed Fashion Designer Masaba Gupta Debuts at Miami Art Week With Unprecedented Celebration of Indian Fashion, Poetry, Dance & Design

GlobeNewswire, Inc.

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Recent French Survey Highlights Religion Discrimination

Deaf Guides Explore Nepal’s Culture, Mountains

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Cold Weather Alert - Overnight December 7, 2025

City transitions water billing services with a streamlined approach

Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting

Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH)…

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human…

Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

MusicBreeds Rebrands as MyndBridge, Unveils 2030 Vision and Launches Direct Tech & AI Certification Pathways

Musical & Artistic Vibes From Across the Globe at Indigenous Holiday Market

Artlanta Experience Set to Dominate Art Basel with a High-Profile Celebration

Bringing Fairy Tales to Life: Grigorii Palamarchuk Unveils 'Reimagined Musicals: Solo Piano' Album

“Art From the Eye of India” Hosted by Luxury Interior Designer Nina Magon, Bestselling Poet Rupi Kaur, and Acclaimed Fashion Designer Masaba Gupta Debuts at Miami Art Week With Unprecedented Celebration of Indian Fashion, Poetry, Dance & Design